MedPath

Butalbital, Aspirin and Caffeine

Butalbital, Aspirin and Caffeine Tablets, USP

Approved
Approval ID

2ef4b16c-f553-4a79-b5ee-7893aeb0eae3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 3, 2012

Manufacturers
FDA

H.J. Harkins Company

DUNS: 147681894

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Butalbital, Aspirin and Caffeine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52959-370
Application NumberANDA086162
Product Classification
M
Marketing Category
C73584
G
Generic Name
Butalbital, Aspirin and Caffeine
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 3, 2012
FDA Product Classification

INGREDIENTS (8)

ASPIRINActive
Quantity: 325 mg in 1 1
Code: R16CO5Y76E
Classification: ACTIB
BUTALBITALActive
Quantity: 50 mg in 1 1
Code: KHS0AZ4JVK
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CAFFEINEActive
Quantity: 40 mg in 1 1
Code: 3G6A5W338E
Classification: ACTIB
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
HYDROGENATED COTTONSEED OILInactive
Code: Z82Y2C65EA
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Butalbital, Aspirin and Caffeine - FDA Drug Approval Details